Patent details

EP3628319 Title: TREATMENT OF HEPATIC ENCEPHALOPATHY USING RIFAXIMIN

Basic Information

Publication number:
EP3628319
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP192075349
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF HEPATIC ENCEPHALOPATHY USING RIFAXIMIN
French Title of Invention:
TRAITEMENT D'UNE ENCÉPHALOPATHIE HÉPATIQUE EN UTILISANT DU RIFAXIMIN
German Title of Invention:
BEHANDLUNG VON HEPATISCHER ENZEPHALOPATHIE UNTER VERWENDUNG VON RIFAXIMIN
SPC Number:

Dates

Filing date:
02/10/2009
Grant date:
14/02/2024
EP Publication Date:
01/04/2020
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/02/2024
EP B1 Publication Date:
14/02/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
02/10/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/03/2024
 
 

Name:
Salix Pharmaceuticals, Inc.
Address:
8450 Colonnade Center Drive, Colonnade 1, Raleigh, NC 27615, United States (US)

History of Owners

From:
07/02/2024
To:
22/03/2024

Name:
Salix Pharmaceuticals, Ltd.
Address:
400 Somerset Corporate Blvd., Bridgewater, NJ 08807, United States (US)

Agent

Name:
NOVAGRAAF BREVETS
From:
15/02/2024
Address:
BÂTIMENT O2, 2 RUE SARAH BERNHARDT CS90017, 92665, ASNIÈRES-SUR-SEINE cedex, France (FR)
To:

Inventor

Name:
FORBES, William
Address:
United States (US)

Priority

Priority Number:
102349 P
Priority Date:
02/10/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/437; A61K 45/06; A61K 31/08; A61K 31/352; A61K 31/4164; A61K 31/426; A61K 31/4439; A61K 31/606; A61K 31/7016; A61K 31/785; A61K 38/14; A61K 38/31; A61P 1/16; A61K 31/395;

Publication

European Patent Bulletin

1

Issue number:
202407
Publication date:
14/02/2024
Description:
Grant (B1)

2

Issue number:
202451
Publication date:
18/12/2024
Description:
Opposition procedure started

3

Issue number:
202410
Publication date:
06/03/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

4

Issue number:
202417
Publication date:
24/04/2024
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/09/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
15/02/2024 Outgoing Correspondence 1
15/02/2024 Power Of Attorney 1